Roy, Soumyajit http://orcid.org/0000-0001-6617-5522
Sun, Yilun
Wallis, Cristopher J. D. http://orcid.org/0000-0002-5990-4026
Morgan, Scott C. http://orcid.org/0000-0002-6568-3346
Grimes, Scott
Malone, Julia
Kishan, Amar U. http://orcid.org/0000-0002-7437-6591
Mukherjee, Dibya
Spratt, Daniel E. http://orcid.org/0000-0002-5973-4741
Saad, Fred http://orcid.org/0000-0003-2986-5617
Malone, Shawn http://orcid.org/0000-0001-5497-3455
Article History
Received: 2 April 2022
Revised: 8 May 2022
Accepted: 1 June 2022
First Online: 5 July 2022
Competing interests
: Outside of this work, Dr. Malone has received honoraria from Astellas, Bayer, Janssen, and Sanofi; and travel and accommodations support from TerSera and Sanofi. Outside of this work, Dr. Morgan reports personal fees from Astellas, Bayer, Janssen, and TerSera. Dr. Roy reports a research grant from Abbvie-Canadian Association of Radiation Oncology. Dr. Wallis reports other from Janssen Oncology, other from SESEN Bio, outside the submitted work. Honoraria. Dr. Kishan reports personal fees and research support from ViewRay, Inc., and personal fees from Varian Medical Systems, Inc., and Intelligent Automation, Inc., outside the submitted work. Dr. Saad reports grants, personal fees, and non-financial support from Janssen, during the conduct of the study; grants, personal fees, and non-financial support from Astellas, grants, personal fees, and non-financial support from Bayer, outside the submitted work. Dr. Spratt reports personal fees from Blue Earth, personal fees from Janssen, personal fees from AstraZeneca, outside the submitted work. The other coauthors have no competing financial interests.